Wealth Science Advisors’s Copart CPRT Stock Holding History

Wealth Science Advisors’s Portfolio CPRT Stock Details CPRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24	Closed	-$940	–	122
2026 Q1	$940	Buy	+24	New	+$902	﹤0.01%	197

Other funds holding CPRT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wealth Science Advisors's CPRT Position: Q2 2026 in Review

Wealth Science Advisors sold out of Copart (CPRT) in Q2 2026, closing a stake of 24 shares — an estimated $940 sold.

Wealth Science Advisors first reported a position in CPRT in Q1 2026 and held it in 1 quarter. The position peaked at $940 in Q1 2026. 1,058 funds tracked by Wall St. Rank hold CPRT as of Q2 2026.

Wealth Science Advisors reported no remaining Copart position as of Q2 2026 after selling out during the quarter.
Wealth Science Advisors sold 24 Copart shares in Q2 2026, an estimated $940.
Wealth Science Advisors first reported a position in Copart in Q1 2026 and held it in 1 quarter.
Wealth Science Advisors's Copart position peaked at $940 in Q1 2026.
1,058 funds tracked by Wall St. Rank held Copart as of Q2 2026.

Based on Wealth Science Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.